Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 80 citing articles:

Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy
Weitong Gao, Yuqin Wang, Yang Zhou, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 612
Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research
Xuhui Tong, Rong Tang, Mingming Xiao, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 490
Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target
Lauren Mifflin, Dimitry Ofengeim, Junying Yuan
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 8, pp. 553-571
Open Access | Times Cited: 344
The therapeutic potential of targeting regulated non-apoptotic cell death
Kamyar Hadian, Brent R. Stockwell
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 9, pp. 723-742
Closed Access | Times Cited: 180
Fueling the Fire: Inflammatory Forms of Cell Death and Implications for Cancer Immunotherapy
Sheera R. Rosenbaum, Nicole A. Wilski, Andrew E. Aplin
Cancer Discovery (2021) Vol. 11, Iss. 2, pp. 266-281
Open Access | Times Cited: 135
Mechanisms of PANoptosis and relevant small-molecule compounds for fighting diseases
Lian Wang, Yanghui Zhu, Lu Zhang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 12
Open Access | Times Cited: 46
RIPK1 inhibitors: A key to unlocking the potential of necroptosis in drug development
Yinliang Bai, Yujun Qiao, Mingming Li, et al.
European Journal of Medicinal Chemistry (2024) Vol. 265, pp. 116123-116123
Closed Access | Times Cited: 18
A RIPK1-specific PROTAC degrader achieves potent antitumor activity by enhancing immunogenic cell death
Jonathan Mannion, Valentina Gifford, Benjamin R. Bellenie, et al.
Immunity (2024) Vol. 57, Iss. 7, pp. 1514-1532.e15
Open Access | Times Cited: 17
Knocking ’em Dead: Pore-Forming Proteins in Immune Defense
Xing Liu, Judy Lieberman
Annual Review of Immunology (2020) Vol. 38, Iss. 1, pp. 455-485
Open Access | Times Cited: 93
Small-Molecule Inhibitors of Necroptosis: Current Status and Perspectives
Chunlin Zhuang, Fen‐Er Chen
Journal of Medicinal Chemistry (2019) Vol. 63, Iss. 4, pp. 1490-1510
Closed Access | Times Cited: 78
Programmed cell death in aortic aneurysm and dissection: A potential therapeutic target
Abhijit Chakraborty, Li Yang, Chen Zhang, et al.
Journal of Molecular and Cellular Cardiology (2021) Vol. 163, pp. 67-80
Open Access | Times Cited: 65
A randomized, placebo-controlled experimental medicine study of RIPK1 inhibitor GSK2982772 in patients with moderate to severe rheumatoid arthritis
Kathleen Weisel, Scott B. Berger, Katie Thorn, et al.
Arthritis Research & Therapy (2021) Vol. 23, Iss. 1
Open Access | Times Cited: 62
The role of necroptosis in disease and treatment
Xiaoxiao Liu, Xin Xie, Yuanyuan Ren, et al.
MedComm (2021) Vol. 2, Iss. 4, pp. 730-755
Open Access | Times Cited: 62
Aβ oligomers trigger necroptosis-mediated neurodegeneration via microglia activation in Alzheimer’s disease
Natalia Salvadores, Inés Moreno‐González, Nazaret Gamez, et al.
Acta Neuropathologica Communications (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 50
Targeting Regulated Cell Death with Pharmacological Small Molecules: An Update on Autophagy-Dependent Cell Death, Ferroptosis, and Necroptosis in Cancer
Junhao Wu, Jing Ye, Qiang Xie, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 4, pp. 2989-3001
Closed Access | Times Cited: 46
From (Tool)Bench to Bedside: The Potential of Necroptosis Inhibitors
Christopher R. Gardner, Katherine A. Davies, Ying Zhang, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 4, pp. 2361-2385
Open Access | Times Cited: 26
Autophagy and necroptosis in cisplatin-induced acute kidney injury: Recent advances regarding their role and therapeutic potential
Noha Alassaf, Hala Attia
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 24
Melanoma biology and treatment: a review of novel regulated cell death-based approaches
Ming-yun Hsieh, Sheng‐Kai Hsu, Tzu‐Yu Liu, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 13
Non-coding RNAs in necroptosis, pyroptosis and ferroptosis in cancer metastasis
Yan Liu, Qiu‐Yun Chen, Yanan Zhu, et al.
Cell Death Discovery (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 56
Inhibition of ADAM17 impairs endothelial cell necroptosis and blocks metastasis
Julia Bolik, Freia Krause, Marija Stevanovic, et al.
The Journal of Experimental Medicine (2021) Vol. 219, Iss. 1
Open Access | Times Cited: 54
Non-Apoptotic Cell Death Signaling Pathways in Melanoma
Mariusz L. Hartman
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 8, pp. 2980-2980
Open Access | Times Cited: 51
Advances in RIPK1 kinase inhibitors
Lu Chen, Xiaoqin Zhang, Yaqing Ou, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 33
Current trends of benzothiazoles in drug discovery: a patent review (2015–2020)
Christine Shing Wei Law, Keng Yoon Yeong
Expert Opinion on Therapeutic Patents (2022) Vol. 32, Iss. 3, pp. 299-315
Closed Access | Times Cited: 31
E3 ligase TRIM28 promotes anti-PD-1 resistance in non-small cell lung cancer by enhancing the recruitment of myeloid-derived suppressor cells
Manman Liang, Zhengui Sun, Xingwu Chen, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 19
Necroptosis inhibitors: mechanisms of action and therapeutic potential
Yingbo Zhou, Zhangtao Cai, Yijia Zhai, et al.
APOPTOSIS (2023) Vol. 29, Iss. 1-2, pp. 22-44
Closed Access | Times Cited: 18
Page 1 - Next Page

Scroll to top